Acke Pharma SRL
Acke Pharma reported total assets of €1.51m at the end of the 2025 financial year (annual accounts filed with the NBB on 05 Jan 2026).
The score of Acke Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +51 % Total assets +2 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Acke Pharma's annual accounts
Filed annual accounts
- Year ended 30 Jun 2025filed on 05 Jan 2026
- Year ended 30 Jun 2024filed on 20 Dec 2024
- Year ended 30 Jun 2023filed on 24 Jan 2024
- Year ended 30 Jun 2022filed on 14 Dec 2022
- Year ended 30 Jun 2021filed on 03 Jan 2022
Acke Pharma's financial analysis
- Solvency60.5%sector median: 58.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Acke Pharma
Acke Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0556.728.728
- VAT number
- BE0556728728
- Peppol
- Registered · 0208:0556728728 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 16 Jul 2014
- Registered office
- 9990 Maldegem
- Latest accounts
- 2025 · filed on 05 Jan 2026
- Activity
- Business and other management consultancy activities (NACE 70200)
Acke Pharma (SRL) has been based in Maldegem since 2014, active in: business and other management consultancy activities. For 2025, it reports a net profit of 76,093 € and equity of 913,023 €; its revenue is not published. Its solvency stands at 60.5%, above the median of its sector (58.4%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Acke Pharma
Companies in the same business, of comparable size and area, outside its group.
- Logistics Tyre Belgium Holding Business and other management consultancy activities Hoogstraten · balance sheet 7,284 €
- Matter Shape Space Business and other management consultancy activities Leuven · balance sheet 7,288 €
- Stena Group Business and other management consultancy activities Vilvoorde · balance sheet 25,585 €
- VASPRO Holding Business and other management consultancy activities Brasschaat · balance sheet 2,018 €
- Nick Pommé Consulting Business and other management consultancy activities Houthulst · balance sheet €1.54m
- Yentl DB Invest Business and other management consultancy activities Brakel · balance sheet €1.56m
- TAS Immobilien Business and other management consultancy activities Aalst · balance sheet €1.45m
- Bicoz Business and other management consultancy activities Ranst · balance sheet €1.44m
Frequently asked questions about Acke Pharma
What is the revenue of Acke Pharma?
Acke Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Acke Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0556728728 for Acke Pharma, if the company is VAT-registered. Its company number (CBE) is 0556.728.728.
Where is the registered office of Acke Pharma?
According to the CBE register, the registered office of Acke Pharma is in 9990 Maldegem.
What is the equity of Acke Pharma?
At the close of the 2025 financial year, the equity of Acke Pharma amounts to 913,023 €, a solvency of 60.5% of total assets.
Who manages Acke Pharma?
The register lists 1 active mandates at Acke Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Acke Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →